Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May 15;229(5):1596.
doi: 10.1093/infdis/jiae053.

Response to Drs de Grooth and Parienti

Mark J Giganti  1 , Kara W Chew  2 , Joseph J Eron  3 , Davey M Smith  4 , Judith S Currier  2 , Michael D Hughes  1
Affiliations

Response to Drs de Grooth and Parienti

Mark J Giganti et al. J Infect Dis. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Potential conflicts of interest. All authors: No reported conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest.

References

    1. Evering TH, Chew KW, Giganti MJ, et al. Safety and efficacy of combination SARS-CoV-2 neutralizing monoclonal antibodies amubarvimab plus romlusevimab in nonhospitalized patients with COVID-19. Ann Intern Med 2023; 176:658–66. - PMC - PubMed
    1. Giganti MJ, Chew KW, Eron JJ, et al. Association between anterior nasal and plasma SARS-CoV-2 RNA levels and hospitalization or death in nonhospitalized adults with mild-to-moderate COVID-19. J Infect Dis 2023; 228(suppl 2):S117–25. - PMC - PubMed
    1. Parienti JJ, de Grooth HJ. Clinical relevance of nasopharyngeal SARS-CoV-2 viral load reduction in outpatients with COVID-19. J Antimicrob Chemother 2022; 77:2038–9. - PMC - PubMed
    1. Hughes MD, DeGruttola V, Welles SL. Evaluating surrogate markers. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 10:S1–8. - PubMed
    1. Daniels MJ, Hughes MD. Meta-analysis for the evaluation of potential surrogate markers. Stat Med 1997; 16:1965–82. - PubMed